Monthwise SARS CoV-2 mutation statistics
Position | Mutation | Clade |
---|---|---|
199 | nsp12:A199T; | CL-3e; |
250 | nsp12:A250S; | CL-3f; |
250 | nsp12:A250T; | CL-3e; |
250 | nsp12:A250V; | CL-2;CL-3b;CL-3c;CL-3e;CL-3f;CL-4; |
253 | nsp12:A253G; | CL-1a; |
253 | nsp12:A253T; | CL-2; |
253 | nsp12:A253V; | CL-1b;CL-2;CL-3e; |
2 | nsp12:A2D; | CL-3a;CL-3f; |
2 | nsp12:A2S; | CL-3b;CL-3d; |
311 | nsp12:A311-; | CL-3b;CL-3e;CL-3f; |
311 | nsp12:A311V; | CL-3d; |
34 | nsp12:A34-; | CL-1b;CL-3b; |
376 | nsp12:A376G; | CL-2; |
379 | nsp12:A379-; | CL-3b;CL-3e; |
379 | nsp12:A379S; | CL-1a_3c;CL-3c;CL-3e; |
379 | nsp12:A379T; | CL-3e; |
382 | nsp12:A382-; | CL-3e; |
383 | nsp12:A383-; | CL-3b;CL-3c;CL-3d;CL-3e;CL-3f; |
383 | nsp12:A383S; | CL-3c;CL-3e;CL-3f; |
399 | nsp12:A399V; | CL-5; |
4 | nsp12:A4-; | CL-3b;CL-3f; |
400 | nsp12:A400-; | CL-2;CL-3e; |
400 | nsp12:A400S; | CL-1a_3e;CL-3d;CL-3e; |
400 | nsp12:A400V; | CL-1a;CL-1a_3b; |
406 | nsp12:A406-; | CL-3d;CL-3e; |
406 | nsp12:A406D; | CL-3d; |
406 | nsp12:A406F; | CL-3b; |
406 | nsp12:A406P; | CL-2; |
406 | nsp12:A406V; | CL-1b;CL-3d;CL-3f;CL-5; |
423 | nsp12:A423-; | CL-3c;CL-3e; |
423 | nsp12:A423V; | CL-3b;CL-3c;CL-3d;CL-3e;CL-3f; |
43 | nsp12:A43-; | CL-3b;CL-3d; |
43 | nsp12:A43V; | CL-3b;CL-3e;CL-3f; |
443 | nsp12:A443-; | CL-3b;CL-3e; |
443 | nsp12:A443D; | CL-5; |
443 | nsp12:A443V; | CL-1a_3b;CL-1a_3e;CL-3b;CL-3d;CL-3e;CL-5; |
448 | nsp12:A448V; | CL-3b; |
449 | nsp12:A449T; | CL-3c;CL-3d; |
4 | nsp12:A4T; | CL-3e; |
512 | nsp12:A512-; | CL-3b; |
526 | nsp12:A526-; | CL-1a;CL-3b;CL-3e;CL-3f; |
526 | nsp12:A526E; | CL-3f; |
529 | nsp12:A529-; | CL-1a;CL-3f; |
529 | nsp12:A529S; | CL-3e; |
529 | nsp12:A529T; | CL-3c; |
547 | nsp12:A547-; | CL-3d; |
550 | nsp12:A550-; | CL-1b;CL-3f; |
554 | nsp12:A554T; | CL-2; |
554 | nsp12:A554V; | CL-2; |
558 | nsp12:A558S; | CL-3e; |
Page 155 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com